» Articles » PMID: 31076879

Adverse Immunological Imprinting by Cytomegalovirus Sensitizing for Allergic Airway Disease

Overview
Date 2019 May 12
PMID 31076879
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cytomegalovirus (CMV) infection has a profound impact on the host's immune system. Immunological imprinting by CMV is not restricted to immunity against CMV itself, but can affect immunity against other viral or non-viral infectious agents and also immunopathological responses. One category is heterologous immunity based on molecular mimicry, where antigen recognition receptors specific for a CMV antigen with broad avidity distribution also bind with some avidity to unrelated antigens and exert effector functions against target structures other than those linked to CMV. Another category is induction of cytokines by CMV infection that inhibit or drive immune responses to bystander antigens unrelated to CMV, and a third category is the activation of antigen-presenting cells by CMV from which unrelated antigens profit as "stowaways". A striking example of the "stowaway" category, actually one that is of medical importance, has been published recently and will be discussed here for the more general reader. Specifically, in a murine model, CMV airway infection and inhaled environmental antigen of poor intrinsic allergenic potential were found to sensitize for allergic airway disease (AAD) only when combined. As to the mechanism, viral activation of CD11b conventional dendritic cells (CD11b cDC) that localize to airway mucosa facilitates uptake and processing of inhaled antigen. Thus, CMV serves as a "door opener" for otherwise harmless environmental antigens that have no intrinsic property to activate DC. Antigen-laden CD11b cDC migrate selectively to the airway draining lymph nodes, where they prime type-2 CD4 T helper (Th-2) cells. Upon airway re-exposure to the inhaled antigen, Th-2 cells secrete interleukins (IL-4, IL-5, IL-9, and IL-25) known to induce goblet cell metaplasia, the lead histopathological manifestation of AAD that is characterized by thickening of airway epithelia and increased numbers of mucus-producing goblet cells, resulting in enhanced mucus secretion and airflow obstruction.

Citing Articles

Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug-controllable interleukin 12.

Jiang H, Nace R, Ferguson C, Zhang L, Peng K, Russell S Cell Rep Med. 2024; 6(1):101874.

PMID: 39694038 PMC: 11866437. DOI: 10.1016/j.xcrm.2024.101874.


Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

Fwambah L, Andisi C, Streatfield C, Bromell R, Hare J, Esbjornsson J Front Immunol. 2024; 14:1283559.

PMID: 38274822 PMC: 10808675. DOI: 10.3389/fimmu.2023.1283559.


Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses.

Jiang H, Nace R, Ariail E, Ma Y, McGlinch E, Ferguson C Mol Ther. 2023; 32(1):241-256.

PMID: 37927036 PMC: 10787119. DOI: 10.1016/j.ymthe.2023.11.003.


The potential roles of interleukin-25 in infectious diseases.

Wu J, Zhang F, Tao H, Nawaz W, Chen D, Wu Z Front Immunol. 2022; 13:986118.

PMID: 36119076 PMC: 9478665. DOI: 10.3389/fimmu.2022.986118.


Mast Cells Meet Cytomegalovirus: A New Example of Protective Mast Cell Involvement in an Infectious Disease.

Becker S, Reddehase M, Lemmermann N Cells. 2022; 11(9).

PMID: 35563708 PMC: 9101682. DOI: 10.3390/cells11091402.


References
1.
Ho M . The history of cytomegalovirus and its diseases. Med Microbiol Immunol. 2007; 197(2):65-73. DOI: 10.1007/s00430-007-0066-x. View

2.
Zhang S, Caldeira-Dantas S, Smith C, Snyder C . Persistent viral replication and the development of T-cell responses after intranasal infection by MCMV. Med Microbiol Immunol. 2019; 208(3-4):457-468. PMC: 6635021. DOI: 10.1007/s00430-019-00589-7. View

3.
Finkelman F, Hogan S, Khurana Hershey G, Rothenberg M, Wills-Karp M . Importance of cytokines in murine allergic airway disease and human asthma. J Immunol. 2010; 184(4):1663-74. PMC: 4122090. DOI: 10.4049/jimmunol.0902185. View

4.
Reddehase M, Lemmermann N . Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time". Viruses. 2018; 10(12). PMC: 6315540. DOI: 10.3390/v10120693. View

5.
Reddehase M . Margaret Gladys Smith, mother of cytomegalovirus: 60th anniversary of cytomegalovirus isolation. Med Microbiol Immunol. 2015; 204(3):239-41. DOI: 10.1007/s00430-015-0416-z. View